調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

再生医療の世界市場予測（～2021年）：細胞治療、組織工学、免疫治療、遺伝子治療

◆タイトル：Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021
◆商品コード：MAM--BT-4419
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年2月10日
◆ページ数：140
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥638,450	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥751,450	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥920,950	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、再生医療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、治療別分析、製品別分析、用途別分析、地域別分析、再生医療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021”
The global Regenerative medicine market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6% from 2016 to 2021
The major factor driving the growth of regenerative medicine market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

The global Regenerative medicine market is segmented based on type, therapy, application, and regions. The cell-based products segment is expected to register to have largest market share in the Regenerative medicine market, by type, during the forecast period. The high growth in this segment is attributed to the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and development of advanced genomic methods.

On the basis of therapy, the cell therapy procedure is expected to account for the largest share of the market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies will drive the growth of this market.

On the basis of applications, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market. Increasing cancer incidence, rich product pipeline and increasing demand for cancer treatments fuelling the growth of the market.

Geographically, the Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rapidly increasing aging population and increase in chronic diseases are the major drivers for developed economies like the U.S.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Research Coverage:
The report analyses the Regenerative medicine market by type, therapy, application and regions. Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the Regenerative medicine market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the Regenerative medicine market.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the Regenerative medicine market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the Regenerative medicine market
• Market Development: Comprehensive information about emerging markets. This report analyses the market for various Regenerative medicine market products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Regenerative medicine market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 13
1.4 CURRENCY 13
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14

2 RESEARCH METHODOLOGY 15
2.1 MARKET SIZE ESTIMATION 16
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 19
2.3 MARKET SHARE ESTIMATION 20
2.3.1 KEY DATA FROM SECONDARY SOURCES 20
2.3.2 KEY DATA FROM PRIMARY SOURCES 21
2.3.3 ASSUMPTIONS FOR THE STUDY 21

3 EXECUTIVE SUMMARY 22

4 PREMIUM INSIGHTS 25
4.1 REGENERATIVE MEDICINE: MARKET OVERVIEW 25
4.2 GEOGRAPHIC ANALYSIS: REGENERATIVE MEDICINE MARKET, BY THERAPY, 2016 26
4.3 GEOGRAPHICAL SNAPSHOT OF THE REGENERATIVE MEDICINE MARKET 27

5 MARKET OVERVIEW 28
5.1 INTRODUCTION 29
5.2 MARKET DYNAMICS 29
5.3 DRIVERS 30
5.3.1 GOVERNMENT & PRIVATE FUNDING TO SUPPORT THE DEVELOPMENT OF REGENERATIVE MEDICINE 30
5.3.2 RISING PREVALENCE OF CHRONIC DISEASES AND GENETIC DISORDERS 30
5.3.3 INCREASE IN GLOBAL HEALTHCARE EXPENDITURE 31
5.3.4 RAPID GROWTH IN THE AGING POPULATION 31
5.3.5 INCREASE IN CORPORATE PARTNERSHIPS TO ACCELERATE DEVELOPMENT AND COMMERCIALIZATION OF REGENERATIVE MEDICINE 32

5.4 RESTRAINTS 33
5.4.1 ETHICAL CONCERNS WITH THE USE OF EMBRYONIC STEM CELL FOR R&D 33
5.4.2 LACK OF CLEAR REGULATORY GUIDELINES 33
5.5 OPPORTUNITIES 34
5.5.1 RISING DEMAND FOR ORGAN TRANSPLANTATION 34
5.5.2 STRONG PRODUCT PIPELINE 34

6 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT 36
6.1 INTRODUCTION 37
6.2 CELL-BASED PRODUCTS 39
6.2.1 ALLOGENEIC PRODUCTS 41
6.2.2 AUTOLOGOUS PRODUCTS 42
6.3 ACELLULAR PRODUCTS 43

7 GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPY 44
7.1 INTRODUCTION 45
7.2 CELL THERAPY 46
7.3 TISSUE ENGINEERING 48
7.4 IMMUNOTHERAPY 49
7.5 GENE THERAPY 50

8 REGENERATIVE MEDICINE MARKET, BY APPLICATION 52
8.1 INTRODUCTION 53
8.2 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS 55
8.3 DERMATOLOGY 56
8.4 CARDIOLOGY 57
8.5 CENTRAL NERVOUS SYSTEM DISEASES 57
8.6 ONCOLOGY 59
8.7 DIABETES 60
8.8 OTHER APPLICATIONS 61

9 GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION 63
9.1 INTRODUCTION 64
9.2 NORTH AMERICA 65
9.2.1 U.S. 69
9.2.2 CANADA 72

9.3 EUROPE 75
9.3.1 GERMANY 79
9.3.2 U.K. 82
9.3.3 FRANCE 84
9.3.4 ITALY 86
9.3.5 SPAIN 88
9.3.6 REST OF EUROPE (ROE) 91
9.4 ASIA-PACIFIC 93
9.5 REST OF THE WORLD (ROW) 98

10 COMPETITIVE LANDSCAPE 102
10.1 OVERVIEW 102
10.2 MARKET RANKING 103
10.3 COMPETITIVE SITUATION AND TRENDS 105
10.3.1 ACQUISITIONS 106
10.3.2 PARTNERSHIPS 107
10.3.3 REGULATORY APPROVALS 108
10.3.4 NEW PRODUCT DEVELOPMENTS 109
10.3.5 OTHERS 110

11 COMPANY PROFILES 111
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 ACELITY L.P. INC. (KCI LICENSING) 111
11.2 NUVASIVE, INC. 113
11.3 VERICEL CORPORATION 115
11.4 OSIRIS THERAPEUTICS, INC. 117
11.5 INTEGRA LIFESCIENCES CORPORATION 119
11.6 STRYKER CORPORATION 122
11.7 MEDTRONIC PLC 124
11.8 COOK BIOTECH INCORPORATED 126
11.9 ORGANOGENESIS INC. 128
11.10 JAPAN TISSUE ENGINEERING CO., LTD. (SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 129
*Details might not be captured in case of unlisted companies.

12 APPENDIX 130
12.1 INSIGHTS FROM INDUSTRY EXPERTS 130
12.2 DISCUSSION GUIDE 131
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
12.5 AVAILABLE CUSTOMIZATIONS 135
12.6 RELATED REPORTS 136
12.7 AUTHOR DETAILS 137

LIST OF TABLES

TABLE 1 KEY CORPORATE PARTNERSHIPS, 2016 32
TABLE 2 GENE THERAPY PRODUCTS IN CLINICAL TRIALS, 2016 34
TABLE 3 CELL AND GENE THERAPY CLINICAL PRODUCT PIPELINE, 2016 34
TABLE 4 GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 38
TABLE 5 CELL-BASED PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 39
TABLE 6 CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 40
TABLE 7 ALLOGENEIC PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 41
TABLE 8 AUTOLOGOUS PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 42
TABLE 9 ACELLULAR PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 43
TABLE 10 GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 46
TABLE 11 STEM CELL THERAPIES IN PHASE III DEVELOPMENT, 2016 47
TABLE 12 CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 48
TABLE 13 TISSUE ENGINEERING MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 49
TABLE 14 IMMUNOTHERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 50
TABLE 15 GENE THERAPIES IN CLINICAL TRIALS, 2016 51
TABLE 16 GENE THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 51
TABLE 17 NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY THERAPEUTIC CATEGORY (2016) 53
TABLE 18 NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY PHASE (2016) 54
TABLE 19 REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 54
TABLE 20 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 55
TABLE 21 DERMATOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 56
TABLE 22 CARDIOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 57
TABLE 23 CENTRAL NERVOUS SYSTEM DISEASES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 58
TABLE 24 CANCER PATIENTS (GLOBAL), BY CANCER TYPE, 2015–2035 59
TABLE 25 ONCOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 60
TABLE 26 DIABETES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 61
TABLE 27 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 62
TABLE 28 GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 64
TABLE 29 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY,
2014–2021 (USD BILLION) 66
TABLE 30 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 67
TABLE 31 NORTH AMERICA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 68
TABLE 32 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014–2021 (USD BILLION) 68
TABLE 33 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 69
TABLE 34 U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 70
TABLE 35 U.S.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 70
TABLE 36 U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 71
TABLE 37 U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 71
TABLE 38 CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 72
TABLE 39 CANADA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 73
TABLE 40 CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 73
TABLE 41 CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 74
TABLE 42 EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY,
2014–2021 (USD BILLION) 76
TABLE 43 EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 77
TABLE 44 EUROPE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 77
TABLE 45 EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 78
TABLE 46 EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 79
TABLE 47 GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 80
TABLE 48 GERMANY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 81
TABLE 49 GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 81
TABLE 50 GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 82
TABLE 51 U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 82
TABLE 52 U.K.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 83
TABLE 53 U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 83
TABLE 54 U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 84
TABLE 55 FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 84
TABLE 56 FRANCE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 85
TABLE 57 FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 85
TABLE 58 FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 86
TABLE 59 ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 87
TABLE 60 ITALY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 87
TABLE 61 ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 87
TABLE 62 ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 88
TABLE 63 SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 89
TABLE 64 SPAIN: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 89
TABLE 65 SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 90
TABLE 66 SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 90
TABLE 67 ROE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 91
TABLE 68 ROE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 91
TABLE 69 ROE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 92
TABLE 70 ROE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 92
TABLE 71 ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 95
TABLE 72 ASIA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 96
TABLE 73 ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 96
TABLE 74 ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2013–2021 (USD BILLION) 97
TABLE 75 ROW: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 99
TABLE 76 ROW: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 99
TABLE 77 ROW: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION,
2014–2021 (USD BILLION) 100
TABLE 78 ROW: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 101
TABLE 79 RANKING OF MAJOR PLAYERS IN THE GLOBAL CELL-BASED REGENERATIVE MEDICINE MARKET (2015) 103
TABLE 80 RANKING OF MAJOR PLAYERS IN THE GLOBAL ACELLULAR REGENERATIVE MEDICINE MARKET (2015) 103
TABLE 81 KEY PRODUCTS IN THE CELL-BASED REGENERATIVE MEDICINE MARKET (2015) 103
TABLE 82 KEY PRODUCTS IN THE ACELLULAR REGENERATIVE MEDICINE MARKET (2015) 104
TABLE 83 ACQUISITIONS, 2014–2017 106
TABLE 84 PARTNERSHIPS, 2014–2016 107
TABLE 85 REGULATORY APPROVALS, 2014–2016 108
TABLE 86 NEW PRODUCT DEVELOPMENTS, 2013–2016 109
TABLE 87 OTHERS, 2014–2016 110

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 15
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 17
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 18
FIGURE 5 DATA TRIANGULATION METHODOLOGY 19
FIGURE 6 CELL-BASED PRODUCTS TO LEAD THE MARKET DURING THE FORECAST PERIOD 22
FIGURE 7 CELL THERAPY TO DOMINATE THE REGENERATIVE MEDICINE MARKET BY 2021 23
FIGURE 8 GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016 VS. 2021 23
FIGURE 9 NORTH AMERICA TO LEAD THE REGENERATIVE MEDICINE MARKET DURING
THE FORECAST PERIOD 24
FIGURE 10 GLOBAL REGENERATIVE MEDICINE MARKET TO REGISTER HIGH, DOUBLE-DIGIT GROWTH FROM 2016 TO 2021 25
FIGURE 11 CELL THERAPY SEGMENT TO DOMINATE THE REGENERATIVE MEDICINE MARKET IN 2016 26
FIGURE 12 ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN THE FORECAST PERIOD 27
FIGURE 13 GLOBAL REGENERATIVE MEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 29
FIGURE 14 GLOBAL REGENERATIVE MEDICINE MARKET SEGMENTATION, BY PRODUCT 37
FIGURE 15 CELL-BASED PRODUCTS TO COMMAND THE LARGEST SHARE OF THE GLOBAL REGENERATIVE MEDICINE MARKET IN 2016 38
FIGURE 16 CELL-BASED PRODUCTS MARKET SEGMENTATION, BY TYPE 40
FIGURE 17 CELL THERAPY TO DOMINATE THE REGENERATIVE MEDICINE MARKET DURING THE FORECAST PERIOD 45
FIGURE 18 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS SEGMENT TO DOMINATE
THE REGENERATIVE MEDICINE APPLICATIONS MARKET IN 2016 54
FIGURE 19 NUMBER OF DIABETES CASES, 2015 VS. 2040 (MILLION) 60
FIGURE 20 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SNAPSHOT 65
FIGURE 21 NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 67
FIGURE 22 U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 70
FIGURE 23 EUROPE: REGENERATIVE MEDICINE MARKET SNAPSHOT 75
FIGURE 24 EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 78
FIGURE 25 GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 80
FIGURE 26 ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SNAPSHOT 93
FIGURE 27 ASIA-PACIFIC.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 95
FIGURE 28 REST OF THE WORLD: REGENERATIVE MEDICINE MARKET SNAPSHOT 98
FIGURE 29 ROW: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY,
2014–2021 (USD BILLION) 100
FIGURE 30 LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST FOUR YEARS (2013–2017) 102
FIGURE 31 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS ARE THE KEY STRATEGIES 105
FIGURE 32 ACELITY (KCI LICENSING): COMPANY SNAPSHOT (2015) 111
FIGURE 33 NUVASIVE, INC.: COMPANY SNAPSHOT (2015) 113
FIGURE 34 VERICEL CORPORATION: COMPANY SNAPSHOT (2015) 115
FIGURE 35 OSIRIS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2014) 117
FIGURE 36 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2015) 119
FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2016) 124
FIGURE 38 JAPAN TISSUE ENGINEERING CO., LTD: COMPANY SNAPSHOT (2015) 129

【レポートのキーワード】

再生医療、細胞治療、組織工学、免疫治療、遺伝子治療、再生医療製品、再生医療用途

★調査レポート[再生医療の世界市場予測（～2021年）：細胞治療、組織工学、免疫治療、遺伝子治療] ( Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021 / MAM--BT-4419) 販売に関する免責事項

[再生医療の世界市場予測（～2021年）：細胞治療、組織工学、免疫治療、遺伝子治療] ( Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021 / MAM--BT-4419) についてEメールでお問い合わせ

◆関連調査資料◆

幹細胞治療の世界市場予測（～2021年）：同種幹細胞、自己幹細胞
MAM-BT5049 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、幹細胞治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、用途別分析、ソース別分析、地域別分析、幹細胞治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and developments in infrastructure related to stem cell banking and processing. In addition, countries such as Japan, South Korea, and China are offering new...

灌流装置の世界市場予測（～2021年）
MAM-MD5190 / MarketsandMarkets / 2017年4月24日 / 当調査レポートでは、灌流装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、装置別分析、技術別分析、地域別分析、灌流装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market. The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion...

セルソーティング（細胞選別）の世界市場予測（～2021年）：セルソーター、試薬、消耗品
MAM-BT4864 / MarketsandMarkets / 2017年1月6日 / MarketsandMarketsが発行した当調査レポートでは、セルソーティング（細胞選別）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、需要先別分析、セルソーティング（細胞選別）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The cell sorting market is expected to reach USD 247.4 Million by 2021 from USD 176.5 Million in 2016, at a CAGR of 7.0% between 2016 and 2021. Factors such as technological advancements in cell sorters, rising funding and investments for development of innovative cell sorting techniques, growing adoption of cell sorter techniques in research activities, and launch of specific reagents for specific applications are driving the growth of this market. However, factors such as the lack of awareness and technical knowledge regarding the use of cell sorters and high cost of instruments are hampering the growth of this market....

メタボロミクス（メタボローム解析）の世界市場予測（～2021年）：ガスクロマトグラフィー、HPLC、UPLC、NMR、マススペクトロメトリー、表面ベース質量分析、バイオインフォマティクス
MAM-BT-2550 / MarketsandMarkets / 2017年3月2日 / 当調査レポートでは、メタボロミクス（メタボローム解析）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、用途別分析、疾患別分析、地域別分析、メタボロミクス（メタボローム解析）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global metabolomics market is estimated to reach USD 2.39 Billion by 2021, at a CAGR of 14.6% during the forecast period. The growing acceptance of metabolomics for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and continuous technological advancements are some of the factors driving market growth. New range of enhanced technologies for accuracy and precision in metabolomics research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, issues related to data examination and processing and high-cost tools and instruments and their maintenance are the major restraining factors for...

集団健康管理（PHM）の世界市場予測（～2021年）
MAM-HIT-2429 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、集団健康管理（PHM）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、構成要素別分析、エンドユーザー別分析、提供方式別分析、地域別分析、集団健康管理（PHM）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The population health management market is projected to reach USD 42.54 Billion by 2021 from USD 13.85 Billion in 2016, at a CAGR of 25.2% in the next five years (2016 to 2021). The implementation of the Affordable Care Act (ACA) in the U.S., government support for the prevention of diseases and adoption of HCIT, rising geriatric population and the subsequent increase in the prevalence of chronic diseases, need for affordable treatment options due to the rising healthcare costs, and advancing IT and big data capabilities are expected to drive the growth of the market in the coming years. The...

バイオマーカーの世界市場予測（～2021年）：安全性マーカー、予測マーカー、代替マーカー、薬力学マーカー、予後マーカー
MAM-BT-2120 / MarketsandMarkets / 2017年2月17日 / 当調査レポートでは、バイオマーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、種類別分析、疾患別分析、用途別分析、バイオマーカーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research are the major factors driving the growth of the global biomarkers market. In recent years, the Asian biomarkers market has witnessed significant growth due to the increasing use of biomarkers for diagnostic purposes, increasing incidence of...

マイクロバイオーム・シーケンシング・サービスの世界市場予測（～2021年）
MAM-BT5306 / MarketsandMarkets / 2017年5月30日 / 当調査レポートでは、マイクロバイオーム・シーケンシング・サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別分析、用途別分析、種類別分析、需要先別分析、マイクロバイオーム・シーケンシング・サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global microbiome sequencing services market is poised to reach USD 1424.7 million by 2021 from USD 538.0 million in 2016, at a CAGR of 21.5% from 2016 to 2021. The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services. In this report, the global microbiome sequencing services market is broadly segmented by technology, application, research type, laboratory type, end user, and region. On the basis of application, the microbiome sequencing services market is segmented into shotgun sequencing, targeted gene...

血液型判定の世界市場予測（～2021年）：消耗品、装置、サービス
MAM-MD5210 / MarketsandMarkets / 2017年4月28日 / 当調査レポートでは、血液型判定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、試験種類別分析、技術別分析、需要先別分析、血液型判定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market. The blood group typing market is segmented based on product & service, technique, test type, end user, and region. On the basis of product & service, the market...

分子診断の世界市場予測（～2021年）
MAM-MD-2521 / MarketsandMarkets / 2017年2月2日 / 当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil,...

注射可能薬剤送達の世界市場予測（～2021年）
MAM-MD-3680 / MarketsandMarkets / 2017年2月6日 / 当調査レポートでは、注射可能薬剤送達の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、治療分野別分析、投与経路別分析、流通チャネル別分析、注射可能薬剤送達の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period. The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors. However, the growing use of alternative delivery...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆